Keep and Share logo     Log In  |  Mobile View  |  Help  
 
Visiting
 
Select a Color
   
 
Abemaciclib API

Abemaciclib API is a highly selective cyclin-dependent kinase 4 (CDK4) and cyclin-dependent kinase 6 (CDK6) inhibitor. CDK4 and CDK6 are two key enzymes that play a critical role in cell cycle regulation. Abemaciclib API works by inhibiting CDK4 and CDK6, which halts the cell cycle progression and leads to apoptosis (programmed cell death) of cancer cells.

Abemaciclib API is used in the treatment of advanced or metastatic breast cancer (ABC/MBC) and hormone receptor-positive, human epidermal growth factor receptor 2-negative (HR+/HER2-) advanced or metastatic non-small cell lung cancer (NSCLC). It is also being investigated for the treatment of other types of cancer, such as colorectal cancer, pancreatic cancer, and ovarian cancer.

Abemaciclib API is typically administered orally once daily in combination with other chemotherapy drugs. It is generally well-tolerated, but common side effects can include diarrhea, nausea, fatigue, and neutropenia (low white blood cell count).

Qingmu Pharm is a leading manufacturer and supplier of abemaciclib API. The company produces high-quality abemaciclib API that is used to manufacture abemaciclib-based medicines around the world.

Here are some of the key details about Qingmu Pharm's abemaciclib API:

  • Product name:Abemaciclib API
  • CAS number:1298869-65-6
  • Molecular formula:C27H31N7O
  • Molecular weight:63 g/mol
  • Appearance:White to light yellow crystalline powder
  • Solubility:Soluble in DMSO, methanol, and ethanol
  • Purity:≥99%

Qingmu Pharm's abemaciclib API is manufactured in accordance with the highest quality standards and is compliant with cGMP and ISO standards. The company's abemaciclib API is registered with regulatory authorities in over 50 countries around the world.


Creation date: Nov 16, 2023 7:41pm     Last modified date: Nov 16, 2023 7:41pm   Last visit date: Jun 11, 2024 4:10am
2 / 20 posts
Dec 28, 2023  ( 1 post )  
12/28/2023
12:41am
Leo Vincey (leovincey40)

Hello, thank you for your information, quite informative. Perhaps my information will help someone, so I want to share my experience of using this wonderful drug. For a long time I had suspicions of brain cancer, I went through a lot of therapy, without this the cancer cells would not go anywhere. On the advice of a doctor, I purchased a powdered glucose preparation 2 dg lab, which with its chemical elements helped me in this treatment.

Nov 16, 2023  ( 1 post )  
11/16/2023
7:41pm
Dora Lee (doralee2303)

Abemaciclib API is a highly selective cyclin-dependent kinase 4 (CDK4) and cyclin-dependent kinase 6 (CDK6) inhibitor. CDK4 and CDK6 are two key enzymes that play a critical role in cell cycle regulation. Abemaciclib API works by inhibiting CDK4 and CDK6, which halts the cell cycle progression and leads to apoptosis (programmed cell death) of cancer cells.

Abemaciclib API is used in the treatment of advanced or metastatic breast cancer (ABC/MBC) and hormone receptor-positive, human epidermal growth factor receptor 2-negative (HR+/HER2-) advanced or metastatic non-small cell lung cancer (NSCLC). It is also being investigated for the treatment of other types of cancer, such as colorectal cancer, pancreatic cancer, and ovarian cancer.

Abemaciclib API is typically administered orally once daily in combination with other chemotherapy drugs. It is generally well-tolerated, but common side effects can include diarrhea, nausea, fatigue, and neutropenia (low white blood cell count).

Qingmu Pharm is a leading manufacturer and supplier of abemaciclib API. The company produces high-quality abemaciclib API that is used to manufacture abemaciclib-based medicines around the world.

Here are some of the key details about Qingmu Pharm's abemaciclib API:

  • Product name:Abemaciclib API
  • CAS number:1298869-65-6
  • Molecular formula:C27H31N7O
  • Molecular weight:63 g/mol
  • Appearance:White to light yellow crystalline powder
  • Solubility:Soluble in DMSO, methanol, and ethanol
  • Purity:≥99%

Qingmu Pharm's abemaciclib API is manufactured in accordance with the highest quality standards and is compliant with cGMP and ISO standards. The company's abemaciclib API is registered with regulatory authorities in over 50 countries around the world.